Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), Agustı́n Ruiz(Biomedical Research Networking Center on Neurodegenerative Diseases), Elena Fonseca(Vall d'Hebron Institut de Recerca), Sílvia Alonso-Lana(University of Oslo), Itziar de Rojas(Instituto de Salud Carlos III), Merçé Boada(Instituto de Salud Carlos III), Miren Ettcheto(Universitat de Barcelona), Xavier Morató(Fundació ACE), Eliana B. Souto(University College Dublin), Elena Sánchez‐López(Centro de Investigación Biomédica en Red), Manuel Toledo(Vall d'Hebron Hospital Universitari), Marta Marquié(Instituto de Salud Carlos III)
Cited by 74
Related Papers
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
|International Journal of Pharmaceutics|2004|664